Kaypeeyes Biotech
Kaypeeyes Biotech is a Private Indian company incorporated in 2004 and based in Karnataka, India. Kaypeeyes Biotech operates in Pharmaceuticals & Chemicals (NIC 24219) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Kaypeeyes Biotech - Manufacturer of enzymes, probiotics and microbial cultures.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Kaypeeyes Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +36d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 24 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Kaypeeyes Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 103942942 | HDFC Bank Ltd(Bank) | ₹8.93 Cr | 12 Mar 2022 | Satisfied |
| 247936747 | Kotak Mahindra Bank Ltd(Bank) | ₹21.61 Cr | 27 Jan 2020 | Satisfied |
| 820098926 | State Bank of India(Bank) | ₹18.72 Cr | 04 Jul 2022 | Satisfied |
| 488808759 | Kotak Mahindra Bank Ltd(Bank) | ₹21.21 Cr | 19 Sep 2019 | Satisfied |
| 595034874 | HDFC Bank Ltd(Bank) | ₹10.57 Cr | 04 Jul 2023 | Open |
| 942064273 | State Bank of India(Bank) | ₹3.15 Cr | 27 Jan 2022 | Satisfied |
Charge IDs, lenders & amounts for Kaypeeyes Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹42.05 Cr | ₹-1.72 Cr | ₹45.72 Cr | ₹66.10 Cr | 361 |
| FY2023-24 | ₹35.30 Cr | ₹-1.08 Cr | ₹30.61 Cr | ₹50.28 Cr | 166 |
| FY2022-23 | ₹35.81 Cr | ₹-1.03 Cr | ₹32.85 Cr | ₹49.49 Cr | 28 |
| FY2021-22 | ₹31.10 Cr | ₹-2.13 Cr | ₹23.83 Cr | ₹39.57 Cr | 241 |
Audited financials & ratios for Kaypeeyes Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹42.05 Cr | ₹35.30 Cr | ₹35.81 Cr | ₹31.10 Cr |
| Other income | ₹60.31 L | ₹22.09 L | ₹1.21 Cr | ₹91.19 L |
| Total income | ₹42.65 Cr | ₹35.52 Cr | ₹37.02 Cr | ₹32.02 Cr |
| Total expenses | ₹44.85 Cr | ₹36.89 Cr | ₹38.33 Cr | ₹34.74 Cr |
| Profit before tax | ₹-2.23 Cr | ₹-1.40 Cr | ₹-1.33 Cr | ₹-2.76 Cr |
| Profit / (Loss) after tax | ₹-1.72 Cr | ₹-1.08 Cr | ₹-1.03 Cr | ₹-2.13 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹45.72 Cr | ₹30.61 Cr | ₹32.85 Cr | ₹23.83 Cr |
| Borrowings | ₹6.38 Cr | ₹6.20 Cr | ₹3.85 Cr | ₹7.19 Cr |
| Current liabilities | ₹8.63 Cr | ₹8.19 Cr | ₹6.42 Cr | ₹6.92 Cr |
| Total liabilities | ₹20.38 Cr | ₹19.67 Cr | ₹16.64 Cr | ₹15.75 Cr |
| Current assets | ₹32.67 Cr | ₹29.00 Cr | ₹25.46 Cr | ₹23.04 Cr |
| Cash & equivalents | ₹10.34 Cr | ₹4.06 Cr | ₹3.65 Cr | ₹7.96 Cr |
| Total assets | ₹66.10 Cr | ₹50.28 Cr | ₹49.49 Cr | ₹39.57 Cr |
| Employees | 361 | 166 | 28 | 241 |
Audited financials & ratios for Kaypeeyes Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹42.05 Cr | +13.8% | +5.4% | -2.6% |
| Profit after Tax | ₹-1.72 Cr | +12.1% | +24.8% | -0.7% |
| Net Worth | ₹45.72 Cr | +17.4% | -1.2% | +0.5% |
| Employees | 361 | +34.8% | +22.7% | +21.1% |
Audited financials & ratios for Kaypeeyes Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹42.05 Cr | ₹-1.72 Cr | -4.08% | +27.67% | -3.75% | -2.59% | 0.14 | ₹11.65 L |
| FY2023-24 | ₹35.30 Cr | ₹-1.08 Cr | -3.05% | +20.21% | -3.52% | -2.14% | 0.20 | ₹21.26 L |
| FY2022-23 | ₹35.81 Cr | ₹-1.03 Cr | -2.87% | +28.50% | -3.12% | -2.07% | 0.12 | ₹1.28 Cr |
| FY2021-22 | ₹31.10 Cr | ₹-2.13 Cr | -6.83% | +36.53% | -8.92% | -5.37% | 0.30 | ₹12.91 L |
Audited financials & ratios for Kaypeeyes Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 2,33,63,155 | 76.09% |
| Institutional Investors | 2 | 29,11,035 | 9.48% |
| Public & Others | 58 | 44,30,370 | 14.43% |
Promoter, institutional & public holding for Kaypeeyes Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
5 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.